21-41480570-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_005656.4(TMPRSS2):​c.478G>A​(p.Val160Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.236 in 1,613,468 control chromosomes in the GnomAD database, including 47,374 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.25 ( 5307 hom., cov: 33)
Exomes 𝑓: 0.23 ( 42067 hom. )

Consequence

TMPRSS2
NM_005656.4 missense

Scores

2
5
10

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts U:1B:2

Conservation

PhyloP100: 1.49

Publications

240 publications found
Variant links:
Genes affected
TMPRSS2 (HGNC:11876): (transmembrane serine protease 2) This gene encodes a protein that belongs to the serine protease family. The encoded protein contains a type II transmembrane domain, a receptor class A domain, a scavenger receptor cysteine-rich domain and a protease domain. Serine proteases are known to be involved in many physiological and pathological processes. This gene was demonstrated to be up-regulated by androgenic hormones in prostate cancer cells and down-regulated in androgen-independent prostate cancer tissue. The protease domain of this protein is thought to be cleaved and secreted into cell media after autocleavage. This protein also facilitates entry of viruses into host cells by proteolytically cleaving and activating viral envelope glycoproteins. Viruses found to use this protein for cell entry include Influenza virus and the human coronaviruses HCoV-229E, MERS-CoV, SARS-CoV and SARS-CoV-2 (COVID-19 virus). Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.001753658).
BP6
Variant 21-41480570-C-T is Benign according to our data. Variant chr21-41480570-C-T is described in ClinVar as Benign. ClinVar VariationId is 1257425.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.373 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TMPRSS2NM_005656.4 linkc.478G>A p.Val160Met missense_variant Exon 6 of 14 ENST00000332149.10 NP_005647.3
TMPRSS2NM_001135099.1 linkc.589G>A p.Val197Met missense_variant Exon 6 of 14 NP_001128571.1
TMPRSS2NM_001382720.1 linkc.478G>A p.Val160Met missense_variant Exon 6 of 14 NP_001369649.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TMPRSS2ENST00000332149.10 linkc.478G>A p.Val160Met missense_variant Exon 6 of 14 1 NM_005656.4 ENSP00000330330.5

Frequencies

GnomAD3 genomes
AF:
0.252
AC:
38327
AN:
152004
Hom.:
5298
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.288
Gnomad AMI
AF:
0.258
Gnomad AMR
AF:
0.157
Gnomad ASJ
AF:
0.138
Gnomad EAS
AF:
0.387
Gnomad SAS
AF:
0.239
Gnomad FIN
AF:
0.394
Gnomad MID
AF:
0.177
Gnomad NFE
AF:
0.228
Gnomad OTH
AF:
0.204
GnomAD2 exomes
AF:
0.245
AC:
61407
AN:
250738
AF XY:
0.244
show subpopulations
Gnomad AFR exome
AF:
0.294
Gnomad AMR exome
AF:
0.153
Gnomad ASJ exome
AF:
0.136
Gnomad EAS exome
AF:
0.381
Gnomad FIN exome
AF:
0.371
Gnomad NFE exome
AF:
0.230
Gnomad OTH exome
AF:
0.224
GnomAD4 exome
AF:
0.234
AC:
342061
AN:
1461346
Hom.:
42067
Cov.:
39
AF XY:
0.234
AC XY:
170309
AN XY:
726950
show subpopulations
African (AFR)
AF:
0.293
AC:
9803
AN:
33476
American (AMR)
AF:
0.153
AC:
6850
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.133
AC:
3488
AN:
26136
East Asian (EAS)
AF:
0.382
AC:
15164
AN:
39696
South Asian (SAS)
AF:
0.244
AC:
21065
AN:
86246
European-Finnish (FIN)
AF:
0.364
AC:
19268
AN:
53006
Middle Eastern (MID)
AF:
0.195
AC:
1124
AN:
5768
European-Non Finnish (NFE)
AF:
0.226
AC:
251562
AN:
1111916
Other (OTH)
AF:
0.227
AC:
13737
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
15497
30995
46492
61990
77487
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8702
17404
26106
34808
43510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.252
AC:
38372
AN:
152122
Hom.:
5307
Cov.:
33
AF XY:
0.259
AC XY:
19230
AN XY:
74384
show subpopulations
African (AFR)
AF:
0.289
AC:
11969
AN:
41482
American (AMR)
AF:
0.157
AC:
2401
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.138
AC:
478
AN:
3470
East Asian (EAS)
AF:
0.388
AC:
2002
AN:
5166
South Asian (SAS)
AF:
0.238
AC:
1147
AN:
4826
European-Finnish (FIN)
AF:
0.394
AC:
4169
AN:
10592
Middle Eastern (MID)
AF:
0.180
AC:
53
AN:
294
European-Non Finnish (NFE)
AF:
0.228
AC:
15484
AN:
67974
Other (OTH)
AF:
0.206
AC:
435
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1474
2948
4423
5897
7371
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
408
816
1224
1632
2040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.232
Hom.:
17308
Bravo
AF:
0.237
TwinsUK
AF:
0.215
AC:
799
ALSPAC
AF:
0.218
AC:
840
ESP6500AA
AF:
0.290
AC:
1279
ESP6500EA
AF:
0.216
AC:
1860
ExAC
AF:
0.249
AC:
30280
Asia WGS
AF:
0.320
AC:
1116
AN:
3478
EpiCase
AF:
0.213
EpiControl
AF:
0.203

ClinVar

Significance: Benign
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Feb 26, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 32867305)

Associated with severe COVID-19 disease Uncertain:1
Jul 01, 2023
HLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:research

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.32
BayesDel_addAF
Benign
-0.43
T
BayesDel_noAF
Benign
-0.25
CADD
Uncertain
25
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.30
T;.;T;.;T
Eigen
Uncertain
0.61
Eigen_PC
Uncertain
0.54
FATHMM_MKL
Uncertain
0.76
D
LIST_S2
Benign
0.0
.;T;T;T;T
MetaRNN
Benign
0.0018
T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Pathogenic
3.3
M;.;M;.;.
PhyloP100
1.5
PrimateAI
Benign
0.47
T
PROVEAN
Benign
-1.9
N;N;N;N;N
REVEL
Benign
0.28
Sift
Uncertain
0.019
D;D;D;D;T
Sift4G
Uncertain
0.0090
D;D;D;D;.
Vest4
0.20
ClinPred
0.059
T
GERP RS
4.2
Varity_R
0.26
gMVP
0.60
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12329760; hg19: chr21-42852497; COSMIC: COSV59820912; API